Double-stranded RNA to mimic viral infection for cancer immunotherapy.

Martinez-Riaño A., Mosteo L., Molero-Glez P., Marquez-Rodas I., Melero I.

The presence of moieties denoting viral infection is crucial to mount powerful cytotoxic T-cell immune responses acting through innate receptors such as Toll-like receptor 3 (TLR3). For cancer immunotherapy, several safe analogues of viral double-stranded RNA (dsRNA) are under clinical development following compelling evidence for efficacy in mouse models.

DOI

10.1158/1078-0432.ccr-24-0938

Type

Journal article

Journal

Clinical cancer research : an official journal of the American Association for Cancer Research

Publication Date

06/2024

Addresses

Clinica Universidad de Navarra, CIBERONC, Pamplona, Navarra, Spain.

Permalink Original publication